ASX biotech firm Noxopharm unveils anti-inflammatory skin disease drug
Australian biotech company Noxopharm Limited unveiled today its new preclinical product candidate from its Sofra technology platform that has shown effectiveness against inflammatory skin disease in preclinical models
Toyota Hilux to get 48V technology in 2024 with 10% better fuel economy
Toyota Australia is set to offer approximately 10 per cent fuel economy improvement for certain HiLux models, compared to the current 2.8-litre turbo diesel variants, when upgraded versions fitted with 48-volt technology arrive in the first half of 2024.
Tritium unveils $57 million record revenue in year-to-date report
Tritium, a Brisbane-based manufacturer of electric vehicle chargers, has generated $57 million in revenue from 1 January 2023 to 30 April 2023, reflecting a year-over-year growth rate of 237 per cent from last year’s $17 million profit.Â
Quickstep to manufacture F-35 components for Northrop Grumman
Northrop Grumman has signed a six-year contract with Quickstep Holdings for the delivery of Australian-made components for the F-35 aerospace program.Â
Australia’s manufacturing PMI hits near three-year high in August – S&P Global
Australia’s manufacturing sector expanded at its fastest pace in nearly three years in August, with stronger demand and a rebound in exports driving higher output, according to the latest S&P Global data.
Cann Group expects record revenue growth of 111% in FY23
Pharmaceutical company Cann Group Limited announced its FY23 unaudited results, with its operating revenue expected to be approximately $13.5 million, representing growth of 111 per cent or 2.1 times compared to the prior year revenue.
Cement maker James Hardie posts $201 million APAC income for Q1 2023
ASX-listed cement manufacturing company James Hardie Industries has posted a $200.1 million revenue from its fibre cement segment sales in the Asia Pacific for...
Austal reports strong growth, eyes further expansion in 2025
Austal Limited has reported strong financial growth in the first half of the 2025 financial year, with earnings exceeding expectations and a record order book supporting future expansion.
Amaero International pays settlements over cancelled Victorian powders project
Additive manufacturing company Amaero International has announced the settlements of two disputes over a cancelled titanium powder production facility in Victoria.Â
EMVision bags $1.75m manufacturing grant payment
Brain imaging company EMVision Medical Devices Limited has received a cash progress payment of $1,750,000 under its Modern Manufacturing Initiative (MMI) grant award.
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
